UBS Group’s Medical Properties Trust MPT Stock Holding History

UBS Group’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,900	Closed	-$9.33K	–	9772
2023 Q4	$9.33K	Buy	+1,900	New	+$9.3K	﹤0.01%	7497
2023 Q3	–	Sell	-70,000	Closed	-$648K	–	9785
2023 Q2	$648K	Buy	70,000 +30,300	+76%	+$256K	﹤0.01%	4602
2023 Q1	$326K	Sell	39,700 -143,700	-78%	-$1.59M	﹤0.01%	5016
2022 Q4	$2.04M	Buy	183,400 +35,000	+24%	+$407K	﹤0.01%	3372
2022 Q3	$1.76M	Buy	+148,400	New	+$2.25M	﹤0.01%	3274
2017 Q4	–	Sell	-8,900	Closed	-$117K	–	7998
2017 Q3	$117K	Sell	8,900 -24,400	-73%	-$314K	﹤0.01%	5221
2017 Q2	$429K	Buy	+33,300	New	+$443K	﹤0.01%	4220

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

UBS Group's MPT Position: Q1 2026 in Review

UBS Group increased its Medical Properties Trust (MPT) stake by 31% in Q1 2026, buying an estimated $3.31M and bringing the position to 2,715,531 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3105.

UBS Group first reported a position in MPT in Q4 2014 and has held it in 46 quarters since. The position peaked at $43.4M in Q3 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

UBS Group held 2,715,531 shares of Medical Properties Trust worth $12.6M as of Q1 2026.
UBS Group bought 635,124 Medical Properties Trust shares in Q1 2026, an estimated $3.31M.
Medical Properties Trust made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3105 holding.
UBS Group first reported a position in Medical Properties Trust in Q4 2014 and has held it in 46 quarters since.
UBS Group's Medical Properties Trust position peaked at $43.4M in Q3 2022.
491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.